Skip to main content
Clinical Trials/JPRN-UMIN000004338
JPRN-UMIN000004338
Completed
未知

Safety and efficacy of umbilical cord blood (UCB) transplantation using a low-dose total body irradiation (TBI) containing regimen for hematologic malignancies - Safety and efficacy of umbilical cord blood (UCB) transplantation using a low-dose total body irradiation (TBI) containing regimen for hematologic malignancies

Hematology, Osaka City University, Graduate School of Meicine0 sites7 target enrollmentOctober 6, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Hematologic malignancies with an indication for allogeneic hematopoietic stem cell transplantation
Sponsor
Hematology, Osaka City University, Graduate School of Meicine
Enrollment
7
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 6, 2010
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hematology, Osaka City University, Graduate School of Meicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\)Patients who have any major organ dysfunction as follow (a) Heart: Ejection fraction \<30% at rest (b) Lung: %VC\<30% or FEV1\.0%\<40% or PaO2\<60mmHg(SpO2\<90%) on room air (c) Kidney: serum creatinine level \>2\.0 mg/dl (d) Liver: total bilirubin level \>2\.0 mg/dl or ALT\>3\.0 x ULN (upper limit of normal) or chronic active hepatitis or cirrhosis (2\) Poorly controlled hypertention (3\) Positivity for HIV antibody (4\) Uncontrolled active infections (5\) Uncontrolled central nervous system involvement (6\) Pregnant, nursing or possibly pregnant woman (7\) Patients with mental disorder who are considered difficult to participate in the study (8\) Known hypersensitivity to any of the drugs in the conditioning regimen or drugs used for GVHD prophylaxis (9\) Patients with positive donor\-specific HLA antibodies(DSA) (10\) Engraftment failure after allogeneic hematopoietic stem cell transplantation (11\) Inappropriate to participate in this study as judged by the physician in charge

Outcomes

Primary Outcomes

Not specified

Similar Trials